ANGIODYNAMICS INC (ANGO) Stock Price & Overview
NASDAQ:ANGO • US03475V1017
The current stock price of ANGO is 10.99 USD. Today ANGO is down by -0.45%. In the past month the price increased by 3.29%. In the past year, price increased by 20.77%.
ANGO Key Statistics
- Market Cap
- 453.008M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.10
- Dividend Yield
- N/A
ANGO Stock Performance
ANGO Stock Chart
ANGO Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to ANGO. When comparing the yearly performance of all stocks, ANGO turns out to be only a medium performer in the overall market: it outperformed 41.37% of all stocks.
ANGO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ANGO. Both the profitability and financial health of ANGO have multiple concerns.
ANGO Earnings
ANGO Forecast & Estimates
10 analysts have analysed ANGO and the average price target is 19.72 USD. This implies a price increase of 79.44% is expected in the next year compared to the current price of 10.99.
For the next year, analysts expect an EPS growth of -97.2% and a revenue growth 9.15% for ANGO
ANGO Groups
Sector & Classification
ANGO Financial Highlights
Over the last trailing twelve months ANGO reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 72.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -10.28% | ||
| ROE | -15.71% | ||
| Debt/Equity | 0.03 |
ANGO Ownership
ANGO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.7 | 197.553B | ||
| ISRG | INTUITIVE SURGICAL INC | 49.03 | 176.649B | ||
| SYK | STRYKER CORP | 25.26 | 147.075B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.62 | 109.521B | ||
| IDXX | IDEXX LABORATORIES INC | 43.78 | 50.748B | ||
| BDX | BECTON DICKINSON AND CO | 10.88 | 49.634B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.66 | 49.488B | ||
| RMD | RESMED INC | 21.1 | 37.626B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.73 | 35.608B | ||
| DXCM | DEXCOM INC | 28.87 | 28.503B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.18 | 19.416B | ||
| PODD | INSULET CORP | 38.31 | 17.013B | ||
| HOLX | HOLOGIC INC | 15.04 | 16.846B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ANGO
Company Profile
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 675 full-time employees. The company went IPO on 2004-05-27. The firm is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. The company designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Company Info
ANGIODYNAMICS INC
14 Plaza Drive
Latham NEW YORK 12110 US
CEO: James C. Clemmer
Employees: 748
Phone: 15187981215
ANGIODYNAMICS INC / ANGO FAQ
What does ANGO do?
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 675 full-time employees. The company went IPO on 2004-05-27. The firm is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. The company designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Can you provide the latest stock price for ANGIODYNAMICS INC?
The current stock price of ANGO is 10.99 USD. The price decreased by -0.45% in the last trading session.
What is the dividend status of ANGIODYNAMICS INC?
ANGO does not pay a dividend.
What is the ChartMill technical and fundamental rating of ANGO stock?
ANGO has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the growth outlook for ANGIODYNAMICS INC?
The Revenue of ANGIODYNAMICS INC (ANGO) is expected to grow by 9.15% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the employee count for ANGO stock?
ANGIODYNAMICS INC (ANGO) currently has 748 employees.
What is the Short Interest ratio of ANGIODYNAMICS INC (ANGO) stock?
The outstanding short interest for ANGIODYNAMICS INC (ANGO) is 4.41% of its float.